Published

Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology
Date: 2012-02-01
Source: PubMed
DOI: 10.1038/npp.2011.228
PubMed: 21956447

Authors

Quednow BB Kometer M Geyer MA Vollenweider FX

Watch author

Derived topics and classifications

psilocybin psilocin Receptor Pharmacology Consciousness Healthy Volunteers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Sex differences and serotonergic mechanisms in the behavioural effects of psilocin2016-06-01 Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain2015-12-01 Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats2015-01-01 Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.2012-02-01

Related papers

No close related records were found yet.